,Column Name,Subject ID,Assessment Panel ID,Study ID,Name Reported,Assessment Type,Status,CRF File Names,Result Separator Column,User Defined ID,Planned Visit ID,Name Reported.1,Study Day,Age At Onset Reported,Age At Onset Unit Reported,Is Clinically Significant,Location Of Finding Reported,Organ Or Body System Reported,Result Value Reported,Result Unit Reported,Result Value Category,Subject Position Reported,Time Of Day,Verbatim Question,Who Is Assessed
0,-,PMID35180044_human_subject-01,PMID35180044_assessment_SCH-01,PMID35180044_study-01,SARS CoV2 History,-,-,-,-,PMID35180044_component_SCH-01,PMID35180044_assessment_recorded_pv,Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
1,-,PMID35180044_human_subject-02,PMID35180044_assessment_SCH-02,PMID35180044_study-01,SARS CoV2 History,-,-,-,-,PMID35180044_component_SCH-02,PMID35180044_assessment_recorded_pv,Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
2,-,PMID35390296_human_subject-01,PMID35390296_assessment_SCH-01,PMID35390296_study-01,SARS CoV2 History,-,-,-,-,PMID35390296_component_SCH-01,PMID35390296_assessment_recorded_pv,Infected | Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
3,-,PMID35390296_human_subject-02,PMID35390296_assessment_SCH-02,PMID35390296_study-01,SARS CoV2 History,-,-,-,-,PMID35390296_component_SCH-02,PMID35390296_assessment_recorded_pv,Infected | Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
4,-,PMID34368647_human_subject-01,PMID34368647_assessment_SCH-01,PMID34368647_study-01,SARS CoV2 History,-,-,-,-,PMID34368647_component_SCH-01,PMID34368647_assessment_recorded_pv,Vaccinated | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
5,-,PMID35284808_human_subject-01,PMID35284808_assessment_SCH-01,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-01,PMID35284808_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
6,-,PMID35284808_human_subject-02,PMID35284808_assessment_SCH-02,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-02,PMID35284808_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
7,-,PMID35284808_human_subject-03,PMID35284808_assessment_SCH-03,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-03,PMID35284808_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
8,-,PMID35284808_human_subject-04,PMID35284808_assessment_SCH-04,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-04,PMID35284808_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
9,-,PMID35284808_human_subject-05,PMID35284808_assessment_SCH-05,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-05,PMID35284808_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
10,-,PMID35284808_human_subject-06,PMID35284808_assessment_SCH-06,PMID35284808_study-01,SARS CoV2 History,Self Reported,-,-,-,PMID35284808_component_SCH-06,PMID35284808_assessment_recorded_pv,Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
11,-,PMID35483404_human_subject-01,PMID35483404_assessment_SCH-01,PMID35483404_study-01,SARS CoV2 History,-,-,-,-,PMID35483404_component_SCH-01,PMID35483404_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
12,-,PMID35483404_human_subject-02,PMID35483404_assessment_SCH-02,PMID35483404_study-01,SARS CoV2 History,-,-,-,-,PMID35483404_component_SCH-02,PMID35483404_assessment_recorded_pv,Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
13,-,PMID34250518_human_subject-01,PMID34250518_assessment_SCH-01,PMID34250518_study-01,SARS CoV2 History,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCH-01,PMID34250518_assessment_recorded_pv,Not vaccinated | Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
14,-,PMID34250518_human_subject-02,PMID34250518_assessment_SCH-02,PMID34250518_study-01,SARS CoV2 History,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCH-02,PMID34250518_assessment_recorded_pv,Partially vaccinated | Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
15,-,PMID34250518_human_subject-03,PMID34250518_assessment_SCH-03,PMID34250518_study-01,SARS CoV2 History,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCH-03,PMID34250518_assessment_recorded_pv,Partially vaccinated | Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
16,-,PMID34250518_human_subject-04,PMID34250518_assessment_SCH-04,PMID34250518_study-01,SARS CoV2 History,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCH-04,PMID34250518_assessment_recorded_pv,Vaccinated | Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
17,-,PMID34250518_human_subject-01,PMID34250518_assessment_SCS-01,PMID34250518_study-01,SARS CoV2 Symptoms,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCS-01,PMID34250518_assessment_recorded_pv,Asymptomatic,0,-,-,-,-,-,-,-,-,-,-,-,-
18,-,PMID34250518_human_subject-02,PMID34250518_assessment_SCS-02,PMID34250518_study-01,SARS CoV2 Symptoms,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCS-02,PMID34250518_assessment_recorded_pv,Asymptomatic,0,-,-,-,-,-,-,-,-,-,-,-,-
19,-,PMID34250518_human_subject-03,PMID34250518_assessment_SCS-03,PMID34250518_study-01,SARS CoV2 Symptoms,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCS-03,PMID34250518_assessment_recorded_pv,Asymptomatic,0,-,-,-,-,-,-,-,-,-,-,-,-
20,-,PMID34250518_human_subject-04,PMID34250518_assessment_SCS-04,PMID34250518_study-01,SARS CoV2 Symptoms,Directly Measured | From Electronic Health Record,Gender | Occupation,-,-,PMID34250518_component_SCS-04,PMID34250518_assessment_recorded_pv,Asymptomatic,0,-,-,-,-,-,-,-,-,-,-,-,-
21,-,PMID34320281_human_subject-01,PMID34320281_assessment_SCH-01,PMID34320281_study-01,SARS CoV2 History,-,-,-,-,PMID34320281_component_SCH-01,PMID34320281_assessment_recorded_pv,Vaccinated | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
22,-,PMID34320281_human_subject-02,PMID34320281_assessment_SCH-02,PMID34320281_study-01,SARS CoV2 History,-,-,-,-,PMID34320281_component_SCH-02,PMID34320281_assessment_recorded_pv,Uninfected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
23,-,PMID35085183_human_subject-01,PMID35085183_assessment_SCH-01,PMID35085183_study-01,SARS CoV2 History,-,-,-,-,PMID35085183_component_SCH-01,PMID35085183_assessment_recorded_pv,Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
24,-,PMID35085183_human_subject-02,PMID35085183_assessment_SCH-02,PMID35085183_study-01,SARS CoV2 History,-,-,-,-,PMID35085183_component_SCH-02,PMID35085183_assessment_recorded_pv,Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
25,-,PMID35085183_human_subject-03,PMID35085183_assessment_SCH-03,PMID35085183_study-01,SARS CoV2 History,-,-,-,-,PMID35085183_component_SCH-03,PMID35085183_assessment_recorded_pv,-,0,-,-,-,-,-,-,-,-,-,-,-,-
26,-,PMID35061630_human_subject-01,PMID35061630_assessment_SCH-01,PMID35061630_study-01,SARS CoV2 History,-,-,-,-,PMID35061630_component_SCH-01,PMID35061630_assessment_recorded_pv,Infected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
27,-,PMID35061630_human_subject-02,PMID35061630_assessment_SCH-02,PMID35061630_study-01,SARS CoV2 History,-,-,-,-,PMID35061630_component_SCH-02,PMID35061630_assessment_recorded_pv,Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
28,-,PMID35704428_human_subject-01,PMID35704428_assessment_SCH-01,PMID35704428_study-01,SARS CoV2 History,-,-,-,-,PMID35704428_component_SCH-01,PMID35704428_assessment_recorded_pv,Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
29,-,PMID35704428_human_subject-02,PMID35704428_assessment_SCH-02,PMID35704428_study-01,SARS CoV2 History,-,-,-,-,PMID35704428_component_SCH-02,PMID35704428_assessment_recorded_pv,Uninfected | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
30,-,PMID35704428_human_subject-03,PMID35704428_assessment_SCH-03,PMID35704428_study-01,SARS CoV2 History,-,-,-,-,PMID35704428_component_SCH-03,PMID35704428_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
31,-,PMID35704428_human_subject-04,PMID35704428_assessment_SCH-04,PMID35704428_study-01,SARS CoV2 History,-,-,-,-,PMID35704428_component_SCH-04,PMID35704428_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
32,-,PMID33688034_human_subject-01,PMID33688034_assessment_SCH-01,PMID33688034_study-01,SARS CoV2 History,-,-,-,-,PMID33688034_component_SCH-01,PMID33688034_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
33,-,PMID35756977_human_subject-01,PMID35756977_assessment_SCS-01,PMID35756977_study-01,SARS CoV2 Symptoms,From Electronic Health Record,-,-,-,PMID35756977_component_SCS-01,PMID35756977_assessment_recorded_pv,Acute COVID-19 (< 4 weeks),0,-,-,-,-,-,-,-,-,-,-,-,-
34,-,PMID35756977_human_subject-02,PMID35756977_assessment_SCS-02,PMID35756977_study-01,SARS CoV2 Symptoms,From Electronic Health Record,-,-,-,PMID35756977_component_SCS-02,PMID35756977_assessment_recorded_pv,Acute COVID-19 (< 4 weeks),0,-,-,-,-,-,-,-,-,-,-,-,-
35,-,PMID35756977_human_subject-01,PMID35756977_assessment_SCH-01,PMID35756977_study-01,SARS CoV2 History,From Electronic Health Record,-,-,-,PMID35756977_component_SCH-01,PMID35756977_assessment_recorded_pv,Infected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
36,-,PMID35756977_human_subject-02,PMID35756977_assessment_SCH-02,PMID35756977_study-01,SARS CoV2 History,From Electronic Health Record,-,-,-,PMID35756977_component_SCH-02,PMID35756977_assessment_recorded_pv,Infected | Vaccinated,0,-,-,-,-,-,-,-,-,-,-,-,-
37,-,PMID35090596_human_subject-01,PMID35090596_assessment_SCH-01,PMID35090596_study-01,SARS CoV2 History,Directly Measured,Gender | Occupation,-,-,PMID35090596_component_SCH-01,PMID35090596_assessment_recorded_pv,Vaccinated | Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
38,-,PMID35090596_human_subject-01,PMID35090596_assessment_SCS-01,PMID35090596_study-01,SARS CoV2 Symptoms,Directly Measured,Gender | Occupation,-,-,PMID35090596_component_SCS-01,PMID35090596_assessment_recorded_pv,Acute COVID-19 (< 4 weeks),0,-,-,-,-,-,-,-,-,-,-,-,-
39,-,PMID34383889_human_subject-01,PMID34383889_assessment_SCH-01,PMID34383889_study-01,SARS CoV2 History,-,Occupation | Education,-,-,PMID34383889_component_SCH-01,PMID34383889_assessment_recorded_pv,Infected ,0,-,-,-,-,-,-,-,-,-,-,-,-
40,-,PMID34383889_human_subject-02,PMID34383889_assessment_SCH-02,PMID34383889_study-01,SARS CoV2 History,-,Occupation | Education,-,-,PMID34383889_component_SCH-02,PMID34383889_assessment_recorded_pv,Infected | Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
41,-,PMID35576468_human_subject-01,PMID35576468_assessment_SCH-01,PMID35576468_study-01,SARS CoV2 History,Directly Measured,-,-,-,PMID35576468_component_SCH-01,PMID35576468_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
42,-,PMID35576468_human_subject-02,PMID35576468_assessment_SCH-02,PMID35576468_study-01,SARS CoV2 History,-,-,-,-,PMID35576468_component_SCH-02,PMID35576468_assessment_recorded_pv,-,0,-,-,-,-,-,-,-,-,-,-,-,-
43,-,PMID34308390_human_subject-01,PMID34308390_assessment_SCH-01,PMID34308390_study-01,SARS CoV2 History,Directly Measured,Gender,-,-,PMID34308390_component_SCH-01,PMID34308390_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
44,-,PMID34308390_human_subject-02,PMID34308390_assessment_SCH-02,PMID34308390_study-01,SARS CoV2 History,Directly Measured,Gender,-,-,PMID34308390_component_SCH-02,PMID34308390_assessment_recorded_pv,Uninfected,0,-,-,-,-,-,-,-,-,-,-,-,-
45,-,PMID35881010_human_subject-01,PMID35881010_assessment_SCH-01,PMID35881010_study-01,SARS CoV2 History,From Electronic Health Record,-,-,-,PMID35881010_component_SCH-01,PMID35881010_assessment_recorded_pv,Infected,0,-,-,-,-,-,-,-,-,-,-,-,-
46,-,PMID35881010_human_subject-01,PMID35881010_assessment_SCS-01,PMID35881010_study-01,SARS CoV2 Symptoms,From Electronic Health Record,-,-,-,PMID35881010_component_SCS-01,PMID35881010_assessment_recorded_pv,Acute COVID-19 (< 4 weeks),0,-,-,-,-,-,-,-,-,-,-,-,-
